Development of Technology of Phytosubstantiation of Silybum marianum L. Fruits as a Component of Complex Therapy of Liver Diseases
Open Access
- 27 October 2023
- journal article
- research article
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
Abstract
Разработка технологии получения фитосубстанции расторопши пятнистой плодов ( Silybum marianum L.) в качестве компонента комплексной терапии заболеваний печениKeywords
This publication has 12 references indexed in Scilit:
- Silymarin in the management of liver enzyme activity in steatohepatitis: a case reportDrugs in Context, 2023
- Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapyWorld Journal of Hepatology, 2023
- Approbation of a Model of Fat Liver Disease Induced by Orotic AcidDrug development & registration, 2022
- Combined hepatoprotective pharmacotherapy for liver diseaseExperimental and Clinical Gastroenterology, 2022
- Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative reviewAnnals of Medicine, 2022
- Silybin and its congeners: from traditional medicine to molecular effectsNatural Product Reports, 2022
- Modification of a model of non-alcoholic fat liver disease in rats with a сombination of a hypercaloric diet and hypodynamiaDrug development & registration, 2021
- Recapitulation of Evidence of Phytochemical, Pharmacokinetic and Biomedical Application of SilybinDrug Research, 2021
- Health Benefits of Silybum marianum: Phytochemistry, Pharmacology, and ApplicationsJournal of Agricultural and Food Chemistry, 2020
- Silymarin as Supportive Treatment in Liver Diseases: A Narrative ReviewAdvances in Therapy, 2020